Inflammation, But Not Telomere Length, Predicts Successful Ageing at Extreme Old Age: A Longitudinal Study of Semi-supercentenarians

EBioMedicine

Volumn 2, Issue 10, 2015, Pages 1549-1558

  Arai, Yasumichi ^a   Martin Ruiz, Carmen M ^b   Takayama, Michiyo ^a   Abe, Yukiko ^a   Takebayashi, Toru ^a   Koyasu, Shigeo ^a,c   Suematsu, Makoto ^a   Hirose, Nobuyoshi ^a   von Zglinicki, Thomas ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Ageing; Centenarian; Inflammation; Telomere

Indexed keywords

AGED; AGING; ARTICLE; COGNITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SENESCENCE; SMOKING; SPOUSE; TELOMERE HOMEOSTASIS; VERY ELDERLY; CAUSE OF DEATH; CELL AGING; GENETICS; IMMUNOSENESCENCE; KAPLAN MEIER METHOD; LONGEVITY; LONGITUDINAL STUDY; METABOLISM; MORBIDITY; TELOMERE;

BIOLOGICAL MARKER;

AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; CAUSE OF DEATH; CELL AGING; FEMALE; HUMANS; IMMUNOSENESCENCE; INFLAMMATION; KAPLAN-MEIER ESTIMATE; LONGEVITY; LONGITUDINAL STUDIES; MALE; MORBIDITY; TELOMERE;

EID: 84949724978     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.07.029     Document Type: Article

References (47)

1. Akbaraly T.N., Hamer M., Ferrie J.E., Lowe G., Batty G.D., Hagger-Johnson G., et al. Chronic inflammation as a determinant of future aging phenotypes. CMAJ 2013, 185:E763-E770.
2. Andersen S.L., Sebastiani P., Dworkis D.A., Feldman L., Perls T.T. Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:395-405.
3. Arai Y., Iinuma T., Takayama M., Takayama M., Abe Y., Fukuda R., et al. The Tokyo Oldest Old survey on Total Health (TOOTH): a longitudinal cohort study of multidimensional components of health and well-being. BMC Geriatr. 2010, 10:35.
4. Arai Y., Inagaki H., Takayama M., Abe Y., Saito Y., Takebayashi T., et al. Physical independence and mortality at the extreme limit of life span: supercentenarians study in Japan. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69:486-494.
5. Atzmon G., Cho M., Cawthon R.M., Budagov T., Katz M., Yang X., et al. Evolution in health and medicine Sackler colloquium: genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(Suppl. 1):1710-1717.
6. Broer L., Codd V., Nyholt D.R., Deelen J., Mangino M., Willemsen G., et al. Meta-analysis of telomere length in 19,713 subjects reveals high heritability, stronger maternal inheritance and a paternal age effect. Eur. J. Hum. Genet. 2013, 21:1163-1168.
7. Caballero B., Vega-Naredo I., Sierra V., DeGonzalo-Calvo D., Medrano-Campillo P., Guerrero J.M., et al. Autophagy upregulation and loss of NF-kappaB in oxidative stress-related immunodeficient SAMP8 mice. Mech. Ageing Dev. 2009, 130:722-730.
8. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko A., Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361:393-395.
9. Derhovanessian E., Maier A.B., Beck R., Jahn G., Hahnel K., Slagboom P.E., et al. Hallmark features of immunosenescence are absent in familial longevity. J. Immunol. 2010, 185:4618-4624.
10. Eisenberg D.T. Inconsistent inheritance of telomere length (TL): is offspring TL more strongly correlated with maternal or paternal TL?. Eur. J. Hum. Genet. 2014, 22:8-9.
11. Fouweather T., Gillies C., Wohland P., Van Oyen H., Nusselder W., Robine J.M., et al. Comparison of socio-economic indicators explaining inequalities in Healthy Life Years at age 50 in Europe: 2005 and 2010. Eur. J. Pub. Health 2015, 10.1093/eurpub/ckv070.
12. Gangemi S., Basile G., Monti D., Merendino R.A., Di Pasquale G., Bisignano U., et al. Age-related modifications in circulating IL-15 levels in humans. Mediat. Inflamm. 2005, 2005:245-247.
13. Gondo Y., Hirose N., Arai Y., Inagaki H., Masui Y., Yamamura K., et al. Functional status of centenarians in Tokyo, Japan: developing better phenotypes of exceptional longevity. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61:305-310.
14. Hardeland R. Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms. J. Pineal Res. 2013, 55:325-356.
15. Hayhoe R.P., Henson S.M., Akbar A.N., Palmer D.B. Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset. Hum. Immunol. 2010, 71:676-681.
16. Hewitt G., Jurk D., Marques F.D., Correia-Melo C., Hardy T., Gackowska A., et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 2012, 3:708.
17. Huntley A.L., Johnson R., Purdy S., Valderas J.M., Salisbury C. Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann. Fam. Med. 2012, 10:134-141.
18. Iinuma T., Arai Y., Abe Y., Takayama M., Fukumoto M., Fukui Y., et al. Denture wearing during sleep doubles the risk of pneumonia in the very elderly. J. Dent. Res. 2015, 94:28S-36S.
19. Jaturapatporn D., Isaac M.G., McCleery J., Tabet N. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. Cochrane Database Syst. Rev. 2012, 2:CD006378.
20. Jenny N.S., French B., Arnold A.M., Strotmeyer E.S., Cushman M., Chaves P.H., et al. Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:970-976.
21. Jurk D., Wilson C., Passos J.F., Oakley F., Correia-Melo C., Greaves L., et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun. 2014, 2:4172.
22. Kawahara T.L., Michishita E., Adler A.S., Damian M., Berber E., Lin M., et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009, 136:62-74.
23. Kimura M., Barbieri M., Gardner J.P., Skurnick J., Cao X., van Riel N., et al. Leukocytes of exceptionally old persons display ultra-short telomeres. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R2210-R2217.
24. Kojima T., Kamei H., Aizu T., Arai Y., Takayama M., Nakazawa S., et al. Association analysis between longevity in the Japanese population and polymorphic variants of genes involved in insulin and insulin-like growth factor 1 signaling pathways. Exp. Gerontol. 2004, 39:1595-1598.
25. Martin-Ruiz C., von Zglinicki T. Biomarkers of healthy ageing: expectations and validation. Proc. Nutr. Soc. 2014, 73:422-429.
26. Martin-Ruiz C.M., Gussekloo J., van Heemst D., von Zglinicki T., Westendorp R.G. Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Aging Cell 2005, 4:287-290.
27. Martin-Ruiz C., Jagger C., Kingston A., Collerton J., Catt M., Davies K., et al. Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study. Mech. Ageing Dev. 2011, 132:496-502.
28. Martin-Ruiz C.M., Baird D., Roger L., Boukamp P., Krunic D., Cawthon R., et al. Reproducibility of telomere length assessment: an international collaborative study. Int. J. Epidemiol. 2014, 10.1093/ije/dyu191.
29. Osorio F.G., Barcena C., Soria-Valles C., Ramsay A.J., de Carlos F., Cobo J., et al. Nuclear lamina defects cause ATM-dependent NF-kappaB activation and link accelerated aging to a systemic inflammatory response. Genes Dev. 2012, 26:2311-2324.
30. Pavlidis N., Stanta G., Audisio R.A. Cancer prevalence and mortality in centenarians: a systematic review. Crit. Rev. Oncol. Hematol. 2012, 83:145-152.
31. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A. Cytomegalovirus and human immunosenescence. Rev. Med. Virol. 2009, 19:47-56.
32. Pellicano R. Gastrointestinal damage by non-steroidal anti-inflammatory drugs: updated clinical considerations. Minerva Gastroenterol. Dietol. 2014, 60:255-261.
33. Rainsford K.D. Anti-inflammatory drugs in the 21st century. Subcell. Biochem. 2007, 42:3-27.
34. Salvioli S., Monti D., Lanzarini C., Conte M., Pirazzini C., Bacalini M.G., et al. Immune system, cell senescence, aging and longevity - inflamm-aging reappraised. Curr. Pharm. Des. 2013, 19:1675-1679.
35. Sansoni P., Vescovini R., Fagnoni F.F., Akbar A., Arens R., Chiu Y.L., et al. New advances in CMV and immunosenescence. Exp. Gerontol. 2014, 55:54-62.
36. Schnabel R.B., Yin X., Larson M.G., Yamamoto J.F., Fontes J.D., Kathiresan S., et al. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1728-1733.
37. Stepanova M., Rodriguez E., Birerdinc A., Baranova A. Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity. Oncotarget 2015, 6:1414-1421.
38. Stevens L.A., Coresh J., Greene T., et al. Assessing kidney function-measured and estimated glomerular filtration rate. N. Engl. J. Med. 2006, 354:2473-2483.
39. Strand V. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?. Lancet 2007, 370:2138-2151.
40. Strindhall J., Nilsson B.O., Lofgren S., Ernerudh J., Pawelec G., Johansson B., et al. No Immune Risk Profile among individuals who reach 100years of age: findings from the Swedish NONA immune longitudinal study. Exp. Gerontol. 2007, 42:753-761.
41. Strong R., Miller R.A., Astle C.M., Floyd R.A., Flurkey K., Hensley K.L., et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 2008, 7:641-650.
42. Takayama M., Hirose N., Arai Y., Gondo Y., Shimizu K., Ebihara Y., et al. Morbidity of Tokyo-area centenarians and its relationship to functional status. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:774-782.
43. Tchkonia T., Zhu Y., van Deursen J., Campisi J., Kirkland J.L. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Invest. 2013, 123:966-972.
44. Tedone E., Arosio B., Gussago C., Casati M., Ferri E., Ogliari G., et al. Leukocyte telomere length and prevalence of age-related diseases in semisupercentenarians, centenarians and centenarians' offspring. Exp. Gerontol. 2014, 58:90-95.
45. Terry D.F., Nolan V.G., Andersen S.L., Perls T.T., Cawthon R. Association of longer telomeres with better health in centenarians. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63:809-812.
46. Tilstra J.S., Robinson A.R., Wang J., Gregg S.Q., Clauson C.L., Reay D.P., et al. NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 2012, 122:2601-2612.
47. Varadhan R., Yao W., Matteini A., Beamer B.A., Xue Q.L., Yang H., et al. Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69:165-173.